Literature DB >> 7384543

Production of thromboxane A2 by the kidney in glycerol-induced acute renal failure in the rabbit.

J E Benabe, S Klahr, M K Hoffman, A R Morrison.   

Abstract

The hemodynamic alterations occuring in glycerol induced renal failure are controversial. To date no single humoral substance can fully explain the change in renal resistance observed in this hemodynamic model of acute renal failure. To assess the capacity of the rabbit kidney to produce thromboxane A2, a potent vasoconstrictor, the following experiments were carried out. Rabbits received 14 ml/kg of 50% glycerol subcutaneously 24 hrs before the study. After 24 hrs., the kidneys were removed and perfused ex vivo in superfusion bioassay cascade. Kidneys from rabbits which developed renal failure, as assessed by elevated serum creatinines, released a substance which produced contraction of rabbit aorta (RCS) in response to bradykinin (BK) and angiotensin II. Microsomes prepared from these kidneys when incubated with [14C]-arachidonic acid produced a peak of radioactivity which comigrated with thromboxane B2 on the thin layer chromatography and was inhibited by the thromboxane synthetase inhibitor imidazole. Furthermore, an inverse linear relation was found between the BK dose required to release RCS from perfused kidney and the serum creatinine levels. A direct linear relation was found between the percent of TxB2 produced by renal microsome preparations and the serum creatinine. These studies demonstrate an increased renal capacity of the glycerol-model of acute renal failure to produce TxA2. The production of TxA2 a potent vasoconstrictor should therefore be further evaluated as a potential endogenous mediator of the hemodynamic changes occurring in acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7384543     DOI: 10.1016/0090-6980(80)90069-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

Review 1.  Introduction: thromboxane in biological systems and the possible impact of its inhibition.

Authors:  M Verstraete
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin.

Authors:  K P Harris; J B Lefkowith; S Klahr; G F Schreiner
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.

Authors:  C Hatziantoniou; N Papanikolaou
Journal:  Experientia       Date:  1986-06-15

4.  Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.

Authors:  C Patrono; G Ciabattoni; G Remuzzi; E Gotti; S Bombardieri; O Di Munno; G Tartarelli; G A Cinotti; B M Simonetti; A Pierucci
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

5.  Peptide-induced prostaglandin biosynthesis in the renal-vein-constricted kidney.

Authors:  S I Myers; R Zipser; P Needleman
Journal:  Biochem J       Date:  1981-08-15       Impact factor: 3.857

6.  Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells.

Authors:  T Okegawa; P E Jonas; K DeSchryver; A Kawasaki; P Needleman
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

Review 7.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01

8.  Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.

Authors:  G Remuzzi; L Imberti; M Rossini; C Morelli; C Carminati; G M Cattaneo; T Bertani
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.